proposed

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:21 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

Walking the Tightrope

Source Node:
Time Stamp: November 15, 2023 5:02 AM - Modified On: November 15, 2023 - Published By:
Source Cluster:
Republished By Plato

As we stand on the verge of a new era in crypto, it’s crucial to reaffirm the importance of decentralization. Beyond being a mere aspiration, decentralization serves as the lifeblood of the crypto world, standing as the pivotal force that draws the line between freedom and control. Amidst the hype surrounding the impending approval of a spot Bitcoin ETF in the United States, accompanied by the influx of capital from behemoths like BlackRock, the immediate market surge raises a serious question for the future of crypto. Are people here for

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:35 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Bitcoin Batteries

Source Node:
Time Stamp: September 14, 2022 2:07 AM - Modified On: September 14, 2022 - Published By:
Source Cluster:
Republished By Plato

In the late 19th Century, a war of great minds was waged in the US between Nikola Tesla and Thomas Edison that would shape the way electricity was delivered throughout the world. Edison proposed using direct current (DC), whereas Tesla favored alternating current (AC), proving that it was far more efficient. Their battle was more than just competing ideologies, it was also a fight between commerce and banks. Edison was backed by J.P.Morgan, the most powerful banker in the US, whereas Tesla was backed by entrepreneur George Westinghouse Jr. Dirty

Axis Technologies Group, INC. (OTCMARKETS: AXTG) Announces Intention to File Registration Statement for Public Offering of Common Stock

Source Node:
Time Stamp: March 30, 2022 2:45 PM - Modified On: March 30, 2022 - Published By:
Source Cluster:
Republished By Plato

California — March. 30, 2022 Axis Technologies Group, Inc. (OTCMARKETS: AXTG) today announced that it intends to file a registration statement with the Securities and Exchange Commission in late April 2022 for a proposed underwritten public offering of common stock. The proposed offering is expected to be predominantly from existing shareholders and be approximately $10 million. The offering is subject to market and other conditions, including the effectiveness of the registration statement to be filed under the Securities Act of 1933, as amended (the “Securities Act”). This announcement is being